MedTrace Logo

An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With Epilepsy

NCT01682681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1234

Last updated 2013-09-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the long-term retention rate of topiramate in participants with epilepsy (seizure disorder).

Conditions

Interventions

DRUG

Topiramate

This is an observational study. Participants with seizures receiving topiramate as per Investigator's discretion will be observed.

Sponsors & Collaborators

  • Janssen Korea, Ltd., Korea

    lead INDUSTRY

Principal Investigators

  • Janssen Korea, Ltd., Korea Clinical Trial · Janssen Korea, Ltd., Korea

Eligibility

Min Age
2 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-05-31
Completion
2009-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01682681 on ClinicalTrials.gov